The price of COLL is predicted to go up 11.18%, based on the high correlation periods with BHE. The similarity of these two price pattern on the periods is 97.89%.
COLL
BHE
Up: 11.18%Similarity: 97.89%
COLL Revenue Forecast
COLL EPS Forecast
COLL FAQs
What is COLL revenue forecast for next quarter?
The market consensus for COLL's revenue in the upcoming quarter is projected to be approximately $175.516M USD.
What is COLL eps forecast for next quarter?
The market consensus for COLL's eps in the upcoming quarter is projected to be approximately $1.61 USD.
Needham upgraded Collegium Pharmaceutical to Buy from Hold with a $46 price target. The analyst cites the company's topline and adjusted EBITDA 2025 guidance coming in above the firm's and consensus estimates. The firm also believes that the stock's current valuation fails to reflect Collegium's top-line growth, profitability and cash-flow generation, all of which have been enhanced by the addition of Jornay PM and its expected $135M top-line contribution while noting that the continued growth and duration of the pain portfolio remain underappreciated.